Literature DB >> 25170325

How Do Clinicians Adjust Lamotrigine Doses and Use Lamotrigine Blood Levels?-A Q-PULSE Survey.

Michael Privitera1, Timothy Welty2, Barry Gidal3, Chad Carlson4, John Pollard5, Michel Berg6.   

Abstract

Entities:  

Year:  2014        PMID： 25170325      PMCID： PMC4120397          DOI： 10.5698/1535-7597-14.4.218

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

1.  Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.

Authors:  K Liow; G L Barkley; J R Pollard; C L Harden; C W Bazil
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

2.  Taking the "Pulse" of Our Society with Q-PULSE.

Authors:  Jacqueline A French
Journal:  Epilepsy Curr       Date:  2013-11       Impact factor: 7.500

3.  Generic substitution of antiepileptic drugs: What's a clinician to do?

Authors:  Michael Privitera
Journal:  Neurol Clin Pract       Date:  2013-04

4.  Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Authors:  Barbara M Davit; Patrick E Nwakama; Gary J Buehler; Dale P Conner; Sam H Haidar; Devvrat T Patel; Yongsheng Yang; Lawrence X Yu; Janet Woodcock
Journal:  Ann Pharmacother       Date:  2009-09-23       Impact factor: 3.154

Review 5.  Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration.

Authors:  Barbara M Davit; Mei-Ling Chen; Dale P Conner; Sam H Haidar; Stephanie Kim; Christina H Lee; Robert A Lionberger; Fairouz T Makhlouf; Patrick E Nwakama; Devvrat T Patel; Donald J Schuirmann; Lawrence X Yu
Journal:  AAPS J       Date:  2012-09-13       Impact factor: 4.009
  5 in total
  1 in total

Review 1.  Risk-Based Bioequivalence Recommendations for Antiepileptic Drugs.

Authors:  Zhichuan Li; Lanyan Fang; Wenlei Jiang; Myong-Jin Kim; Liang Zhao
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09-19       Impact factor: 5.081
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.